Two recent studies have carefully characterized amyloid-related brain insulin resistance in animal models of, and patients with, Alzheimer disease (AD). The researchers show that exendin-4, a glucagon-like peptide 1 receptor agonist, ameliorates pathology and symptoms in a mouse model of AD, suggesting a novel therapeutic approach to this disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model
Scientific Reports Open Access 06 January 2023
-
Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders
Molecular Brain Open Access 25 March 2019
-
The role of melatonin in the onset and progression of type 3 diabetes
Molecular Brain Open Access 01 August 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hoyer, S. & Nitsch, R. Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J. Neural. Transm. 75, 227–232 (1989).
Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338 (2012).
Bomfim, T. R. et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J. Clin. Invest. 122, 1339–1353 (2012).
Ma, Q.-L. et al. β-Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078–9089 (2009).
Cao, D., Lu, H., Lewis, T. L. & Li, L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 282, 36275–36282 (2007).
Ho, L. et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J. 18, 902–904 (2004).
Zhao, L. et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J. Neurosci. 24, 11120–11126 (2004).
Sivertsen, J., Rosenmeier, J., Holst, J. J. & Vilsboll, T. The effect of glucagon-like peptide 1 on cardiovascular risk. Nat. Rev. Cardiol. 9, 209–222 (2012).
Craft, S. et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29–38 (2012).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
S. Craft receives research support from Kurve Technology in the form of insulin delivery devices.
Rights and permissions
About this article
Cite this article
Craft, S. Insulin resistance and AD—extending the translational path. Nat Rev Neurol 8, 360–362 (2012). https://doi.org/10.1038/nrneurol.2012.112
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.112
This article is cited by
-
Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model
Scientific Reports (2023)
-
Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
Metabolic Brain Disease (2023)
-
Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders
Molecular Brain (2019)
-
Chronic Metabolic Derangement-Induced Cognitive Deficits and Neurotoxicity Are Associated with REST Inactivation
Molecular Neurobiology (2019)
-
Cross-fibrillation of insulin and amyloid β on chiral surfaces: Chirality affects aggregation kinetics and cytotoxicity
Nano Research (2018)
